RxDoctor Payments Data

Christopher Manning

Rheumatology · Southington, CTNPI 1437124963

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,760 of the $8,663 with a category attached, or 66.5%. 32 manufacturers reported payments, led by Amgen at 44.8% of the total. Reporting peaked in 2019 at $4,217 and has fallen 97.6% since, to $101 in 2023.

$8,663in general payments, 2019–2025

Across 366 payments — averaging $23.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$4K
  • Johnson & Johnson$584
  • Mallinckrodt Hospital Products Inc.$495
  • AbbVie$402
  • Lilly USA, LLC$360
  • Pfizer$349
  • plus $3K from 26 others

What the payments were for

  • Speaking & faculty fees$2,25026%
  • Travel & lodging$1572%
  • Food & beverage$5,76066%
  • Education$4966%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,663 in reported general payments places this provider in the 75th percentile of 118 rheumatology providers in Connecticut.

See all rheumatology providers in Connecticut

Other rheumatology in Southington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →